Literature DB >> 28404707

An efficient tool for the primary care management of menopause.

Susan Goldstein1.   

Abstract

Mesh：

Year:  2017        PMID： 28404707      PMCID： PMC5389763     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  11 in total

1.  2016 IMS Recommendations on women's midlife health and menopause hormone therapy.

Authors:  R J Baber; N Panay; A Fenton
Journal:  Climacteric       Date:  2016-02-12       Impact factor: 3.005

2.  The 2013 British Menopause Society & Women's Health Concern recommendations on hormone replacement therapy.

Authors:  Nick Panay; Haitham Hamoda; Roopen Arya; Michael Savvas
Journal:  Menopause Int       Date:  2013-05-23

3.  The North American Menopause Society Statement on Continuing Use of Systemic Hormone Therapy After Age 65.

Authors: 
Journal:  Menopause       Date:  2015-07       Impact factor: 2.953

4.  The North American Menopause Society recommendations for clinical care of midlife women.

Authors:  Jan L Shifren; Margery L S Gass
Journal:  Menopause       Date:  2014-10       Impact factor: 2.953

5.  Duration of menopausal vasomotor symptoms over the menopause transition.

Authors:  Nancy E Avis; Sybil L Crawford; Gail Greendale; Joyce T Bromberger; Susan A Everson-Rose; Ellen B Gold; Rachel Hess; Hadine Joffe; Howard M Kravitz; Ping G Tepper; Rebecca C Thurston
Journal:  JAMA Intern Med       Date:  2015-04       Impact factor: 21.873

6.  A prospective population-based study of menopausal symptoms.

Authors:  L Dennerstein; E C Dudley; J L Hopper; J R Guthrie; H G Burger
Journal:  Obstet Gynecol       Date:  2000-09       Impact factor: 7.661

7.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

8.  Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.

Authors:  JoAnn E Manson; Rowan T Chlebowski; Marcia L Stefanick; Aaron K Aragaki; Jacques E Rossouw; Ross L Prentice; Garnet Anderson; Barbara V Howard; Cynthia A Thomson; Andrea Z LaCroix; Jean Wactawski-Wende; Rebecca D Jackson; Marian Limacher; Karen L Margolis; Sylvia Wassertheil-Smoller; Shirley A Beresford; Jane A Cauley; Charles B Eaton; Margery Gass; Judith Hsia; Karen C Johnson; Charles Kooperberg; Lewis H Kuller; Cora E Lewis; Simin Liu; Lisa W Martin; Judith K Ockene; Mary Jo O'Sullivan; Lynda H Powell; Michael S Simon; Linda Van Horn; Mara Z Vitolins; Robert B Wallace
Journal:  JAMA       Date:  2013-10-02       Impact factor: 56.272

9.  Managing menopause.

Authors:  Robert Reid; Beth L Abramson; Jennifer Blake; Sophie Desindes; Sylvie Dodin; Shawna Johnston; Timothy Rowe; Namrita Sodhi; Penny Wilks; Wendy Wolfman
Journal:  J Obstet Gynaecol Can       Date:  2014-09

10.  Can depression be a menopause-associated risk?

Authors:  Claudio N Soares
Journal:  BMC Med       Date:  2010-12-01       Impact factor: 8.775
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.